KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Depreciation & Amortization (CF) (2016 - 2026)

Rigel Pharmaceuticals has reported Depreciation & Amortization (CF) over the past 16 years, most recently at $601000.0 for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) changed 0.5% year-over-year to $601000.0; the TTM value through Dec 2025 reached $2.4 million, up 8.39%, while the annual FY2025 figure was $2.4 million, 8.39% up from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $601000.0 at Rigel Pharmaceuticals, roughly flat from $603000.0 in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $613000.0 in Q2 2024 and troughed at $237000.0 in Q1 2022.
  • A 5-year average of $402050.0 and a median of $326500.0 in 2023 define the central range for Depreciation & Amortization (CF).
  • Biggest five-year swings in Depreciation & Amortization (CF): decreased 29.7% in 2022 and later surged 109.25% in 2024.
  • Year by year, Depreciation & Amortization (CF) stood at $404000.0 in 2021, then fell by 29.7% to $284000.0 in 2022, then increased by 3.17% to $293000.0 in 2023, then surged by 106.14% to $604000.0 in 2024, then fell by 0.5% to $601000.0 in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for RIGL at $601000.0 in Q4 2025, $603000.0 in Q3 2025, and $607000.0 in Q2 2025.